Aspen Pharmacare Current Ratio 2017-2023 | APNHY

Aspen Pharmacare current ratio from 2017 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Aspen Pharmacare Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2023-06-30 $2.51B $1.31B 1.92
2022-12-31 $2.25B $0.94B 2.40
2022-06-30 $2.27B $1.54B 1.48
2021-12-31 $2.37B $1.21B 1.96
2021-06-30 $2.13B $2.40B 0.89
2020-12-31 $2.79B $1.29B 2.16
2020-06-30 $2.37B $1.16B 2.03
2019-06-30 $2.55B $1.41B 1.80
2018-12-31 $3.17B $1.55B 2.05
2018-06-30 $3.14B $2.20B 1.43
2017-12-31 $2.65B $2.97B 0.89
2017-06-30 $2.80B $2.56B 1.10
2016-12-31 $2.61B $1.76B 1.48
2016-06-30 $2.58B $1.46B 1.76
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $4.985B $2.296B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.585B 5.27
Dr Reddy's Laboratories (RDY) India $11.930B 18.86
BridgeBio Pharma (BBIO) United States $4.477B 0.00
Bausch Health Cos (BHC) Canada $3.117B 2.43
Amphastar Pharmaceuticals (AMPH) United States $1.999B 13.68
Supernus Pharmaceuticals (SUPN) United States $1.639B 0.00
Taysha Gene Therapies (TSHA) United States $0.473B 0.00
Generation Bio (GBIO) United States $0.217B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.070B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00